0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
28 Ansichten8 Seiten
13-valent Pneumococcal Conjugate Vaccine (PCV13) is efficacious against vaccine-type nonbacteremic pneumonia in adults. Adding PCV13 at age 65 or replacing PPSV23 at age 65 with PCV13 provided more value for money. But anticipated herd protection from the childhood immunization program may dramatically increase the cost per QALY gained.
13-valent Pneumococcal Conjugate Vaccine (PCV13) is efficacious against vaccine-type nonbacteremic pneumonia in adults. Adding PCV13 at age 65 or replacing PPSV23 at age 65 with PCV13 provid…